Subscribe
Back to list

David C. Linehan

CEO

University of Rochester Medicine

Rochester, NY

Dr. Linehan assumed the dual role of CEO of the University of Rochester Medical Center and dean of the Schools of Medicine and Dentistry in February 2024, bringing to the position a decade of leadership as chair of the medical center’s department of surgery and a distinguished career as a surgical oncologist and accomplished surgeon-scientist. As top executive of the enterprise, he oversees UR Medicine, the medical, dentistry and nursing schools, and the Eastman Institute for Oral Health. Holding the Seymour I. Schwartz Professorship in Surgery, Dr. Linehan has specialized in treating cancers and benign surgical conditions of the liver, pancreas, gallbladder and bile ducts, and is recognized for bringing novel and innovative therapies to patients with difficult-to-treat cancers. His research laboratory, internationally renowned for its work on new immunotherapy treatments for pancreatic cancer, has been continuously funded by the National Cancer Institute for nearly two decades, and his bench-to-bedside work at UR Medicine’s Wilmot Cancer Institute has attracted and promoted the growth of surgeon-scientists across the enterprise. Recruited from Washington University School of Medicine in St. Louis in 2014, Dr. Linehan is deeply committed to the organization’s tripartite mission of patient care, research and education.

Becker's Recognition

David C. Linehanhas been named a Becker's honoree on the lists below.

2026 Winner

Great Leaders in Healthcare

Healthcare is rapidly evolving and the best leaders have embraced change and are leading organizations on the forefront of transforming care delivery. The below leaders are using innovative digital technology, novel care delivery approaches and creative care solutions to shape the future of healthcare.

Newsletter

Join the 500,000+
healthcare executives
who start their day with
Becker’s

You can unsubscribe from these communications at any time. For more information, please review
our Privacy Policy.
More Newsletters